Sign-up for our newsletter
MAIN
Event Calendar
Awardee Reports
ABOUT DIACOMP
Citing DiaComp
Contact
Committees
Institutions
Awardee Reports
Publications
Bioinformatics
RESOURCES
Protocols & Methods
Reagents & Resources
Mouse Diet
Breeding Schemes
Validation Criteria
IMPC / KOMP Data
Publications
Bioinformatics
CONTACT
PARTICIPANT AREA
Login
▹
Publications
▹
Home
Publication
Detecting and assessing macrophages in vivo to evaluate atherosclerosis
noninvasively using molecular MRI.
Authors
Amirbekian V, Lipinski MJ, Briley-Saebo KC, Amirbekian S, Aguinaldo JG, Weinreb
DB, Vucic E, Frias JC, Hyafil F, Mani V, Fisher EA, Fayad ZA
Submitted By
Submitted Externally on 3/4/2015
Status
Published
Journal
Proceedings of the National Academy of Sciences of the United States of America
Year
2007
Date Published
1/16/2007
Volume : Pages
104 : 961 - 966
PubMed Reference
17215360
Abstract
We investigated the ability of targeted immunomicelles to detect and assess
macrophages in atherosclerotic plaque using MRI in vivo. There is a large
clinical need for a noninvasive tool to assess atherosclerosis from a molecular
and cellular standpoint. Macrophages play a central role in atherosclerosis and
are associated with plaques vulnerable to rupture. Therefore, macrophage
scavenger receptor (MSR) was chosen as a target for molecular MRI. MSR-targeted
immunomicelles, micelles, and gadolinium-diethyltriaminepentaacetic acid (DTPA)
were tested in ApoE-/- and WT mice by using in vivo MRI. Confocal laser-scanning
microscopy colocalization, macrophage immunostaining and MRI correlation,
competitive inhibition, and various other analyses were performed. In vivo MRI
revealed that at 24 h postinjection, immunomicelles provided a 79% increase in
signal intensity of atherosclerotic aortas in ApoE-/- mice compared with only
34% using untargeted micelles and no enhancement using gadolinium-DTPA. Confocal
laser-scanning microscopy revealed colocalization between fluorescent
immunomicelles and macrophages in plaques. There was a strong correlation
between macrophage content in atherosclerotic plaques and the matched in vivo
MRI results as measured by the percent normalized enhancement ratio. Monoclonal
antibodies to MSR were able to significantly hinder immunomicelles from
providing contrast enhancement of atherosclerotic vessels in vivo.
Immunomicelles provided excellent validated in vivo enhancement of
atherosclerotic plaques. The enhancement seen is related to the macrophage
content of the atherosclerotic vessel areas imaged. Immunomicelles may aid in
the detection of high macrophage content associated with plaques vulnerable to
rupture.
Investigators with authorship
Name
Institution
Edward Fisher
New York University School of Medicine
Complications
All Complications
Bioinformatics
Bone
Cardiomyopathy
Cardiovascular
Gastro-Intestinal (GI)
Nephropathy
Neuropathy & Neurocognition
Pediatric Endocrinology
Retinopathy
Uropathy
Wound Healing
Welcome to the DiaComp Login / Account Request Page.
Email Address:
Password:
Note: Passwords are case-sensitive.
Please save my Email Address on this machine.
Not a member?
If you are a funded DiaComp investigator, a member of an investigator's lab,
or an External Scientific Panel member to the consortium, please
request an account.
Forgot your password?
Enter your Email Address and
click here.
ERROR!
There was a problem with the page:
User Info
User Confirm
Please acknowledge all posters, manuscripts or scientific materials that were generated in part or whole using funds from the Diabetic Complications Consortium(DiaComp) using the following text:
Financial support for this work provided by the NIDDK Diabetic Complications Consortium (RRID:SCR_001415, www.diacomp.org), grants DK076169 and DK115255
Citation text and image have been copied to your clipboard. You may now paste them into your document. Thank you!